COEP
NASDAQCoeptis Therapeutics Holdings Inc.
Price$16.27+3.31 (+25.54%)
2026-01-212026-04-24
News · 26 weeks42+160%
2025-11-022026-04-26
Mix3190d
- Insider15(48%)
- SEC Filings10(32%)
- Other6(19%)
Latest news
25 items- INSIDERSEC Form 3 filed by new insider Sohn Adam Craig3 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERSEC Form 3 filed by new insider Schadel Christopher Ryan3 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERNew insider Halabu David Elias claimed ownership of 1,412,855 shares (SEC Form 3)3 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERSEC Form 3 filed by new insider Fuerst Bryan Eric3 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cooper Kenneth Lyle3 - Z Squared Inc. (0001759186) (Issuer)
- INSIDERSEC Form 3 filed by new insider Burke Michelle Ellen3 - Z Squared Inc. (0001759186) (Issuer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
- SECSEC Form 25-NSE filed by Coeptis Therapeutics Holdings Inc.25-NSE - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
- PRZ Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market~ Shares to Commence Trading on the Nasdaq Global Market Under Ticker Symbol "ZSQR" Monday April 27, 2026 ~FORT LAUDERDALE, Fla, April 24, 2026 /PRNewswire/ -- Z Squared, Inc. (NASDAQ:ZSQR) ("Z Squared" or the "Company"), a vertically integrated computing infrastructure company, today announced the completion of its business combination with Coeptis Therapeutics Holdings, Inc. ("Coeptis"). In connection with the business combination, the combined company has been renamed "Z Squared Inc." and its public shares are expected to commence trading on the Nasdaq Global Market under the ticker symbol "ZSQR" on Monday, April 27, 2026 (CUSIP: 98878K108). The closing follows the satisfaction of all con
- SECSEC Form 424B3 filed by Coeptis Therapeutics Holdings Inc.424B3 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
- SECCoeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
- PRCoeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing Application~ Approval Marks Satisfaction of Key Closing Condition in Pending Merger ~ WEXFORD, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, today announced that Nasdaq has approved, subject to customary conditions and the closing of the proposed merger, the listing of the post-merger Company's common stock on the Nasdaq Global Market under the ticker symbol "ZSQR". The new listing is expected to become effective upon the closing of the proposed merger between the Company and Z Squared, Inc., pursuant to which Z Squared will become a wholly owned subsidiary of Coeptis and th
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Coeptis Therapeutics Holdings Inc.SCHEDULE 13G/A - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)
- SECSEC Form 424B3 filed by Coeptis Therapeutics Holdings Inc.424B3 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
- SECSEC Form 424B3 filed by Coeptis Therapeutics Holdings Inc.424B3 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
- SECSEC Form 424B3 filed by Coeptis Therapeutics Holdings Inc.424B3 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
- SECSEC Form 10-K filed by Coeptis Therapeutics Holdings Inc.10-K - Coeptis Therapeutics Holdings, Inc. (0001759186) (Filer)
- INSIDERDirector Deschamps Philippe exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares, increasing direct ownership by 175% to 8,950 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- INSIDERChief Financial Officer Cogley Brian exercised 10,000 shares at a strike of $10.56 and was granted 12,500 shares, increasing direct ownership by 80% to 22,500 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- INSIDERDirector Cochran Christopher P. exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares, increasing direct ownership by 175% to 8,950 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- INSIDERDirector Salkind Gene exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- INSIDERDirector Calise Chris exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- INSIDERVP Operations Yerace Daniel Alexander was granted 20,000 shares and exercised 10,000 shares at a strike of $10.41, increasing direct ownership by 17% to 70,531 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
- INSIDERCEO and President Mehalick David exercised 148,875 shares at a strike of $7.05 and was granted 51,250 shares, increasing direct ownership by 82% to 330,192 units (SEC Form 4)4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
COEP FAQ
5 questionsWhere does COEP stock trade?
Coeptis Therapeutics Holdings Inc. (COEP) is listed on NASDAQ.What sector and industry is COEP in?
Coeptis Therapeutics Holdings Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Coeptis Therapeutics Holdings Inc. go public?
Coeptis Therapeutics Holdings Inc. (COEP) completed its IPO in 2020.What companies are similar to COEP?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), BIIB (Biogen Inc.), RVMD (Revolution Medicines Inc.). Compare COEP side-by-side with any of them on Quantisnow.How can I track COEP on Quantisnow?
Quantisnow aggregates Coeptis Therapeutics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COEP to receive live email and push alerts on every new disclosure.